Webinar Overview
PANIC Spring Webinar
As the importance and number of Oligonucleotide therapeutics grows, so too does the need for characterization methodologies both during drug development and production. Because structure is so intricately entwined in therapeutic efficacy for this class of drug, detailed characterization of structure is critical. Nuclear Magnetic Resonance (NMR) can deliver detailed structural information that spans the breadth of the different oligonucleotide-base therapies being developed. This webinar will detail some of the latest advancements in NMR oligonucleotide-based drug characterization.
Tuesday, 12 March 2024, 11:00 ES
Presentations
- The vital role of NMR in analyzing nucleic acids’ structure and dynamics for small molecule drug discovery advancements
Celestine Chi, AstraZeneca - Multi-attribute assessment of anti-sense therapeutics
Robert Brinson, IBBR, NIST - NMR of RNA and therapeutic oligonucleotides
Martial Piotto, Bruker BioSpin
Key Learning Topics
- Different approaches to the characterization of oligonucleotide therapeutic with NMR
- Pharmaceutical trends and requirements for oligonucleotide-based therapeutics
- Latest developments from Bruker to address requirements in characterization of oligonucleotide and other macromolecular therapeutics.